helpline 01494 601 400


Phase 3 clinical trial announced for Dravet Syndrome drug

The second Phase 3 clinical trial is to begin for ZX008, a branded version of low-dose fenfluramine, designed as an adjunctive treatment of seizures in children with Dravet syndrome.

Study finds that taking once- a-day epilepsy drug may be as effective as a multiple dose drug at preventing seizures


A new preliminary study has found that an anti-epileptic drug that can be taken once a day to control seizures may work as effectively as a drug that must be taken twice a day.

Studies expose efficacy of two widely-prescribed epilepsy drugs

Two separate studies have analysed the benefits and side-effects of two antiepileptic drugs, rufinamide and retigabine.

Subscribe to RSS - drug